- $1.17bn
- $1.15bn
- $1.31bn
- 58
- 70
- 58
- 64
Annual balance sheet for Revelyst, fiscal year end - March 31st, millions except per share.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | 10-K | 10-K | |
Standards: | — | USG | USG |
Status: | fx Preliminary | Final | Final |
Cash and Equivalents | |||
Cash and Short Term Investments | — | 15.5 | 22.9 |
Net Total Accounts Receivable | |||
Net Total Receivables | — | 202 | 211 |
Total Inventory | |||
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | — | 664 | 557 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | — | 171 | 161 |
Net Goodwill | |||
Net Intangible Assets | |||
Other Long Term Assets | |||
Total Assets | — | 1,951 | 1,575 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Total Other Current Liabilities | |||
Total Current Liabilities | — | 204 | 206 |
Total Long Term Debt | |||
Total Debt | |||
Deferred Income Tax | |||
Total Other Liabilities | |||
Total Liabilities | — | 365 | 341 |
Retained Earnings (Accumulated Deficit) | |||
Other Equity | |||
Total Equity | — | 1,586 | 1,234 |
Total Liabilities & Shareholders' Equity | — | 1,951 | 1,575 |
Total Common Shares Outstanding |